[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 4th Subcommittee on Non-clinical Studies
Press Release
Date and Time: March 11, 2015 from 10am to 12pm
Agenda / List of Handouts
Agenda
- Non-clinical studies from a viewpoint of the regulatory authority (PMDA)
- Towards summary of the past discussions
- Others
List of Handouts
- Document 1-1 Cases of non-clinical pharmacology studies of oncology drugs
- Document 1-2 Cases of non-clinical pharmacology studies of oncology drugs(Modified version of the material of #1-1 for publishing purposes)
- Document 2 Summary outline of the discussions in the Subcommittee on Non-clinical Studies (Draft)